This summary was created by AI, based on 2 opinions in the last 12 months.
Alteryx Inc. is a data analytics company that allows users to work with streams of data without having to be a coder. The company has faced challenges with higher interest rates in the past but has now stabilized. Experts believe that the company has a great long runway and a strong appeal due to its ability to gather data from different locations and assimilate it into one package. The stock has a 12-month price target of $69 and an analysts' price target of $46.47, indicating potential for future growth.
Appeal is that everybody can work with streams of data, without having to be a coder. The whole data analytics side is only as good as the data. Benefit is that it gathers data from different locations, assimilating it into one package. Was very leveraged, so got clobbered with higher interest. Has now found its grounding.
Great long runway, his 12-month price target is $69. No dividend.
Alteryx Inc is a American stock, trading under the symbol AYX-N on the New York Stock Exchange (AYX). It is usually referred to as NYSE:AYX or AYX-N
In the last year, 1 stock analyst published opinions about AYX-N. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Alteryx Inc.
Alteryx Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Alteryx Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Alteryx Inc In the last year. It is a trending stock that is worth watching.
On 2024-03-18, Alteryx Inc (AYX-N) stock closed at a price of $48.27.
If it gets within 10% of price target, take at least 1/3 off the table. If it goes higher, you still own it. If it goes lower, you can buy back the 1/3 you took off. Designed for this age of AI. Add back down at $47, and then $45.
(Analysts’ price target is $54.50)